title: Maternal Anti-Fetal Brain IgG Autoantibodies and Autism Spectrum Disorder: Current Knowledge and its Implications for Potential Therapeutics.
abstract: Several studies have found a correlation between the presence of circulating maternal autoantibodies and neuronal dysfunction in the neonate. Specifically, maternal anti-brain autoantibodies, which may access the fetal compartment during gestation, have been identified as one risk factor for developing autism spectrum disorder (ASD). Studies by our laboratory elucidated seven neurodevelopmental proteins recognized by maternal autoantibodies whose presence is associated with a diagnosis of maternal autoantibody-related (MAR) autism in the child. While the specific process of anti-brain autoantibody generation is unclear and the detailed pathogenic mechanisms are currently unknown, identification of the maternal autoantibody targets increases the therapeutic possibilities. The potential therapies discussed in this review provide a framework for possible future medical interventions.
authors.affiliation: Division of Rheumatology/Allergy and Clinical Immunology, University of California, Davis, 451 E. Health Sciences Drive, Suite 6510 GBSF, Davis, CA, 95616, USA.|The M.I.N.D. Institute, University of California, Davis, Davis, CA, 95616, USA.
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Fox-Edmiston
authors.affiliation: Division of Rheumatology/Allergy and Clinical Immunology, University of California, Davis, 451 E. Health Sciences Drive, Suite 6510 GBSF, Davis, CA, 95616, USA. javandewater@ucdavis.edu.|The M.I.N.D. Institute, University of California, Davis, Davis, CA, 95616, USA. javandewater@ucdavis.edu.|NIEHS Center for Children's Environmental Health, University of California, Davis, Davis, CA, 95616, USA. javandewater@ucdavis.edu.
authors.forename: Judy
authors.initials: J
authors.lastname: Van de Water
mesh_terms: D000067877:Autism Spectrum Disorder / Q000209:etiology* / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D001323:Autoantibodies / Q000276:immunology*; D001921:Brain / Q000378:metabolism* / Q000473:pathology; D005260:Female; D005333:Fetus; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D011247:Pregnancy; D012307:Risk Factors
chemical_list: D001323:Autoantibodies; D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors